Tissue distribution and integrated pharmacokinetic properties of major effective constituents of oral Gegen-Qinlian decoction in mice

Tissue distribution and integrated pharmacokinetic properties of major effective constituents of oral Gegen-Qinlian decoction in mice

Gegen-Qinlian decoction (GQD) is a classic traditional Chinese medicine (TCM) formula. GQD is effective against colon or liver-related diseases including ulcerative colitis, non-alcoholic fatty liver, and type 2 diabetes. In this study, a liquid chromatography-tandem mass spectrometry method was dev...

Full description

Bibliographic Details
Main Authors:	Jing-Ze Lu, Dan-Dan Hong, Dan Ye, Sheng Mu, Rong Shi, Yu Song, Chu Feng, Bing-Liang Ma
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Pharmacology
Subjects:	gegen-qinlian decoction effective constituents integrated pharmacokinetics tissue distribution LC-MS/MS
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.996143/full

Similar Items

Constituents, Pharmacokinetics, and Pharmacology of Gegen-Qinlian Decoction
by: Jing-Ze Lu, et al.
Published: (2021-05-01)

Gegen Qinlian Decoction treatment of asymptomatic hyperuricemia by targeting circadian immune function
by: Xiaojun Wang, et al.
Published: (2023-06-01)

A 42-Markers Pharmacokinetic Study Reveals Interactions of Berberine and Glycyrrhizic Acid in the Anti-diabetic Chinese Medicine Formula Gegen-Qinlian Decoction
by: Xue Qiao, et al.
Published: (2018-06-01)

Gegen Qinlian decoction (GQD) inhibits ulcerative colitis by modulating ferroptosis-dependent pathway in mice and organoids
by: Xue Wang, et al.
Published: (2023-08-01)

Gegen Qinlian Decoction Ameliorates Hyperuricemia-Induced Renal Tubular Injury via Blocking the Inflammatory Signaling Pathway
by: Xiao-Jun Wang, et al.
Published: (2021-05-01)

The potential effects and mechanisms of Gegen Qinlian Decoction in oxaliplatin-resistant colorectal cancer based on network pharmacology
by: Xiang Lin, et al.
Published: (2022-11-01)

Metformin and Gegen Qinlian Decoction boost islet α-cell proliferation of the STZ induced diabetic rats
by: Li Xu, et al.
Published: (2022-07-01)

Integrated Pharmacology Reveals the Molecular Mechanism of Gegen Qinlian Decoction Against Lipopolysaccharide-induced Acute Lung Injury
by: Wei Li, et al.
Published: (2022-05-01)

Network Pharmacology–Based Analysis and Experimental Exploration of Antidiabetic Mechanisms of Gegen Qinlian Decoction
by: Yu Xu, et al.
Published: (2021-07-01)

Gegen Qinlian Decoction Treats Diarrhea in Piglets by Modulating Gut Microbiota and Short-Chain Fatty Acids
by: Chang-Shun Liu, et al.
Published: (2019-04-01)

Gegen-Qinlian decoction alleviates anxiety-like behaviors in methamphetamine-withdrawn mice by regulating Akkermansia and metabolism in the colon
by: Xue Lu, et al.
Published: (2023-07-01)

Exploration of the Mechanism of the Control of Coccidiosis in Chickens Based on Network Pharmacology and Molecular Docking With the Addition of Modified Gegen Qinlian Decoction
by: Xiaomin Peng, et al.
Published: (2022-03-01)

In Silico and In Vivo Studies on the Mechanisms of Chinese Medicine Formula (Gegen Qinlian Decoction) in the Treatment of Ulcerative Colitis
by: Xiaolu Liu, et al.
Published: (2021-06-01)

Exploring the mechanism and key active components of Gegen Qinlian decoction combined with XELOX in the treatment of ulcerative colitis-associated colorectal cancer based on network pharmacology and multi-omics analysis
by: Qi Tang, et al.
Published: (2024-03-01)

Gegen Qinlian Decoction Alleviates Experimental Colitis and Concurrent Lung Inflammation by Inhibiting the Recruitment of Inflammatory Myeloid Cells and Restoring Microbial Balance
by: Li Y, et al.
Published: (2022-02-01)

Gegen Qinlian Decoction Coordinately Regulates PPARγ and PPARα to Improve Glucose and Lipid Homeostasis in Diabetic Rats and Insulin Resistance 3T3-L1 Adipocytes
by: Jun Tu, et al.
Published: (2020-06-01)

Efficacy and safety of Gegen Qinlian decoction in the treatment of type II diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials
by: YiMei Tan, et al.
Published: (2024-01-01)

Gegen Qinlian standard decoction alleviated irinotecan-induced diarrhea via PI3K/AKT/NF-κB axis by network pharmacology prediction and experimental validation combination
by: Jiamei Chen, et al.
Published: (2023-04-01)

Modified Gegen Qinlian Decoction Regulates Treg/Th17 Balance to Ameliorate DSS-Induced Acute Experimental Colitis in Mice by Altering the Gut Microbiota
by: Yifan Wang, et al.
Published: (2021-11-01)

Gegen Qinlian decoction restores the intestinal barrier in bacterial diarrhea piglets by promoting Lactobacillus growth and inhibiting the TLR2/MyD88/NF-κB pathway
by: Zhenye Luo, et al.
Published: (2022-11-01)

The mechanisms underlying olanzapine-induced insulin resistance via the brown adipose tissue and the therapy in rats
by: Jing Wang, et al.
Published: (2022-12-01)

Comparative Pharmacokinetics of Hypaconitine after Oral Administration of Pure Hypaconitine, Aconitum carmichaelii Extract and Sini Decoction to Rats
by: Wen Zhang, et al.
Published: (2015-01-01)

The cardioprotective effect of danshen and gegen decoction on rat hearts and cardiomyocytes with post-ischemia reperfusion injury
by: Hu Fan, et al.
Published: (2012-12-01)

Simultaneous Determination of Seven Components in Rat Plasma by the UPLC-MS/MS Method and Application of Pharmacokinetic Studies to SimiaoYong’an Decoction
by: Yuanyan Liu, et al.
Published: (2017-11-01)

Identification of Polar Constituents in the Decoction of Juglans mandshurica and in the Medicated Egg Prepared with the Decoction by HPLC-Q-TOF MS2
by: Tian-Min Wang, et al.
Published: (2017-09-01)

Pharmacokinetics of Cyadox and Its Major Metabolites in Swine After Intravenous and Oral Administration
by: Ning ZHAO, et al.
Published: (2013-03-01)

Shengjiang Xiexin Decoction Alters Pharmacokinetics of Irinotecan by Regulating Metabolic Enzymes and Transporters: A Multi-Target Therapy for Alleviating the Gastrointestinal Toxicity
by: Huan-yu Guan, et al.
Published: (2017-10-01)

Metabolic profiling and pharmacokinetic studies of Baihu-Guizhi decoction in rats by UFLC-Q-TOF–MS/MS and UHPLC-Q-TRAP-MS/MS
by: Yan He, et al.
Published: (2022-10-01)

Comparison of pharmacokinetic profiles of seven major bioactive components in normal and non-alcoholic fatty liver disease (NAFLD) rats after oral administration of Ling-Gui-Zhu-Gan decoction by UPLC-MS/MS
by: Wenlong Nie, et al.
Published: (2023-05-01)

Development and validation of an LC-MS/MS method for pharmacokinetic study of lobetyolin in rats
by: Haitao Tian, et al.
Published: (2023-01-01)

Quantification of Acipimox in Plasma and Tissues by LC–MS/MS: Application to Pharmacokinetic Comparison between Normoxia and Hypoxia
by: Xin Shen, et al.
Published: (2022-09-01)

Largazole Pharmacokinetics in Rats by LC-MS/MS
by: Mingming Yu, et al.
Published: (2014-03-01)

Development of a UHPLC-MS/MS method for the quantification of ilaprazole enantiomers in rat plasma and its pharmacokinetic application
by: Fengting Ou, et al.
Published: (2020-12-01)

Quantification of Paeoniflorin by Fully Validated LC–MS/MS Method: Its Application to Pharmacokinetic Interaction between Paeoniflorin and Verapamil
by: Bin Bao, et al.
Published: (2022-11-01)

Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans
by: Lourdes Poyatos, et al.
Published: (2022-11-01)

An effective UFLC–MS/MS method used to study pharmacokinetics of major constituents of Fukeqianjin formula in rat plasma
by: Kanghua Wang, et al.
Published: (2020-07-01)

Development of a Liquid Chromatography–Tandem Mass Spectrometry (LC–MS/MS) Method for Characterizing Linalool Oral Pharmacokinetics in Humans
by: Yan-Hong Wang, et al.
Published: (2023-09-01)

Quantitative determination of metaxalone in human plasma by LC-MS and its application in a pharmacokinetic study
by: Lanting Zhao, et al.
Published: (2016-10-01)

Simultaneous determination of bicyclol and its two active metabolites concentration in rat plasma and application for pharmacokinetics study of bicyclol and optimized bicyclol-nanoparticles
by: Xucong Huang, et al.
Published: (2023-12-01)

Effects of type 2 diabetes mellitus on the pharmacokinetics of berberine in rats
by: Yuzhen Jia, et al.
Published: (2017-01-01)